Matches in Nanopublications for { ?s ?p "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP407097.RAtTDKvNs9JXQvWEiWWf05nALkIMHI7FCppaKGJ33hy78130_assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407097.RAtTDKvNs9JXQvWEiWWf05nALkIMHI7FCppaKGJ33hy78130_provenance.
- NP189166.RAMetcaJeXFDB0udNF7Aj64jCQUmDxlDyd_ArcLsbRH1c130_assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189166.RAMetcaJeXFDB0udNF7Aj64jCQUmDxlDyd_ArcLsbRH1c130_provenance.
- assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921441.RANWe9tdwjsokalydBI0s9XqNrBHlLhudkJMeYGhfgXKs130_provenance.
- NP570193.RAvIyPeP2MgpFEYS7CJra2eYWOTGRqRfca8LB9zzhlZk8130_assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570193.RAvIyPeP2MgpFEYS7CJra2eYWOTGRqRfca8LB9zzhlZk8130_provenance.
- NP570188.RA5B8cJjG6bEk1a3sN7Hg2wQ0YqMu7QA0G2u7TilvUkgw130_assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570188.RA5B8cJjG6bEk1a3sN7Hg2wQ0YqMu7QA0G2u7TilvUkgw130_provenance.